See other companies on Welcome to the Jungle
Syapse
Evidence and insights to advance care
- 101-200 employees
- Healthcare
- B2B
- Data Analysis
- Wellbeing
- The East Cut, San Francisco, CA
Jump to section
Company mission
To improve clinical outcomes by providing patients with more precise, personalized care.
-21% employee growth in 12 months
Our take
Syapse operates a global network comprising top-tier health systems, life sciences firms, and regulatory bodies. This network grants access to cutting-edge genomic sequencing and treatment records, allowing healthcare providers to enhance cancer diagnoses and patient care.
Driving Syapse's network is its data platform, Raydar, which is meticulously constructed on a foundation of data intelligence, practical experience, and insightful analytics. This platform enables physicians to access treatment data and patient outcomes from across the country, leveraging this valuable information to make more informed treatment decisions for their own patients.
The company has established a productive research partnership with the US FDA, working collaboratively to address critical public health challenges, including the COVID-19 pandemic. Additionally, Syapse has engaged in collaboration with pharmaceutical giants such as Merck. As it continues to contribute insights on the treatment of emerging conditions, Syapse remains committed to its mission of advancing precise and personalized healthcare.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Annual bonus based on personal and company performance
- 401k with match
- flexible PTO
Funding (last 2 of 9 rounds)
Jul 2022
$35m
LATE VC
Feb 2021
$68m
GROWTH EQUITY VC
Total funding: $222.6m
This company has top investors
Leadership
Tony Loeser
(Founder)Having studied at Stanford, Tony worked as a Computer Scientist at Kestrel and a Software Engineer at Ingenuity Systems for 6 years. They worked as an Independent Consultant for over 4 years before co-founding Syapse in May 2008.